Filing Details
- Accession Number:
- 0000899243-18-020957
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-01 16:05:54
- Reporting Period:
- 2018-07-30
- Accepted Time:
- 2018-08-01 16:05:54
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1434647 | Kempharm Inc | KMPH | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1083033 | G Andrew Bluhm | 900 North Michigan Suite 1600 Chicago IL 60611 | No | No | Yes | No | |
1299434 | Dsc Advisors, L.p. | 900 North Michigan Suite 1600 Chicago IL 60611 | No | No | Yes | No | |
1648574 | Dsc Advisors, L.l.c. | 900 North Michigan Suite 1600 Chicago IL 60611 | No | No | Yes | No | |
1648576 | Delaware Street Capital Master Fund, L.p. | 900 North Michigan Suite 1600 Chicago IL 60611 | No | No | Yes | No | |
1648612 | Dsc Managers, L.l.c. | 900 North Michigan Suite 1600 Chicago IL 60611 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.0001 | Acquisiton | 2018-07-30 | 304,283 | $4.00 | 2,095,914 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The filing of this Form 4 shall not be construed as an admission that DSC Advisors, L.P. ("DSCA), the investment manager of Delaware Street Master Fund, L.P. (the "Fund"), DSC Managers, L.L.C. ("DSCM"), the general partner of the Fund, DSC Advisors, L.L.C. ("DSCA LLC"), the general partner of DSCA, or Andrew G. Bluhm, the principal of DSCA LLC, is or was for the purposes of Section 16(a) of the Securities Exchange Act of 1934, as amended, or otherwise the beneficial owner of any of the Common Stock, par value $0.0001 (the "Common Stock"), of KemPharm, Inc. (the "Issuer") purchased by the Fund. Pursuant to Rule 16a-1, each of DSCA, DSCM, DSCA LLC and Mr. Bluhm disclaim such beneficial ownership.
- The Fund holds the shares of Common Stock directly. DSCA serves as the investment manager to the Fund. DSCA LLC serves as the general partner of DSCA. DSCM receives a portion of the profits in the form of a capital allocation from, and owns a partnership interest in, the Fund. Andrew G. Bluhm reports the Common Stock held directly by the Fund because, as the principal of DSCA LLC at the time of purchase, he controlled the disposition and voting of the securities.